Douglas M. Molina

About

Douglas M. Molina is a distinguished researcher whose work centers on the immunology and vaccinology of parasitic diseases, with a particular focus on malaria. His major contributions lie in the development and application of cutting-edge proteomic tools to unravel host-pathogen interactions. Molina is best known for his pivotal role in evaluating the RTS,S malaria vaccine, the world’s first licensed malaria vaccine. His highly cited 2014 study (39 citations) provided critical serologic evidence that RTS,S vaccination reduces exposure to *Plasmodium falciparum* during both liver and blood stages, offering key insights into the vaccine’s mechanism of partial protection. Beyond this, Molina has advanced the field through the use of protein microarrays for high-throughput parasite antigen discovery (21 citations), a technique that accelerates the identification of novel vaccine targets and diagnostic markers. His work has directly informed global malaria control strategies and vaccine development pipelines. By bridging molecular biology and field immunology, Molina has established himself as a leading figure in translational parasitology, helping to shape the next generation of interventions against devastating infectious diseases.

Research Focus

Key Achievements

Top Papers

1. 1
   RTS,S Vaccination Is Associated With Serologic Evidence of Decreased Exposure to Plasmodium falciparum Liver- and Blood-Stage Parasites*

   39 citations · 2014
2. 2
   Protein Microarrays for Parasite Antigen Discovery

   21 citations · 2014

Key Collaborators

Contact & Links